HK Stock MarketDetailed Quotes
06606 NH HEALTH
- 14.140
- 0.0000.00%
Market Closed Apr 23 16:09 CST
6.47BMarket Cap53.36P/E (TTM)
0.000High0.000Low0Volume14.140Open14.140Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)457.81MShares32.55052wk High2.00P/B6.47BFloat Cap13.76052wk Low--Dividend TTM457.81MShs Float89.650Historical High--Dividend LFY0.00%Amplitude12.700Historical Low--Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
NH HEALTH Key Stats
All
YOY
| (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q9)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 264.58%822.68M | 259.54%764.96M | 413.65%225.65M | 201.50%212.76M | 317.36%43.93M | 21.09%70.57M | -0.37%35.31M | -20.05%10.53M | 209.71%58.28M | --35.44M |
| Operating income | 264.58%822.68M | 259.54%764.96M | 413.65%225.65M | 201.50%212.76M | 317.36%43.93M | 21.09%70.57M | -0.37%35.31M | -20.05%10.53M | 209.71%58.28M | 35.44M |
| Cost of sales | -85.32%-75.17M | -104.40%-118.79M | -110.81%-40.56M | -74.43%-58.12M | -132.34%-19.24M | -39.07%-33.32M | -27.93%-18.77M | 4.84%-8.28M | -59.97%-23.96M | ---14.68M |
| Operating expenses | -85.32%-75.17M | -104.40%-118.79M | -110.81%-40.56M | -74.43%-58.12M | -132.34%-19.24M | -39.07%-33.32M | -27.93%-18.77M | 4.84%-8.28M | -59.97%-23.96M | -14.68M |
| Gross profit | 303.86%747.5M | 317.84%646.17M | 649.68%185.09M | 315.17%154.65M | 1,000.22%24.69M | 8.54%37.25M | -20.37%16.54M | -49.72%2.24M | 793.70%34.32M | 20.77M |
| Selling expenses | -191.42%-574.07M | -104.54%-555.08M | -170.79%-196.99M | -316.72%-271.38M | -247.87%-72.75M | 13.87%-65.12M | -4.34%-38.24M | -50.38%-20.91M | -191.26%-75.61M | ---36.65M |
| Administrative expenses | -121.01%-130.74M | -46.00%-159.59M | -29.24%-59.16M | -42.05%-109.31M | -56.17%-45.77M | -42.87%-76.95M | -35.74%-50.77M | -27.40%-29.31M | -17.16%-53.86M | ---37.4M |
| Research and development expenses | -82.72%-74.75M | -60.60%-94.6M | -92.66%-40.91M | -132.50%-58.9M | -102.80%-21.24M | 3.93%-25.34M | -0.46%-17.36M | 0.44%-10.47M | -78.44%-26.37M | ---17.28M |
| Impairment and provision | -185.10%-21.75M | -223.07%-21.43M | -97.54%-7.63M | -158.15%-6.63M | -140.47%-3.86M | -187.68%-2.57M | -125.34%-1.83M | -346.11%-1.61M | -337.75%-893K | ---813K |
| -Other impairment is provision | -185.10%-21.75M | -223.07%-21.43M | -97.54%-7.63M | -158.15%-6.63M | -140.47%-3.86M | -187.68%-2.57M | -125.34%-1.83M | -346.11%-1.61M | -337.75%-893K | ---813K |
| Special items of operating profit | 23.52%71.46M | 104.03%112.23M | 102.09%57.85M | -329.97%-2.79B | -465.09%-2.77B | -3,816.85%-647.96M | -4,670.78%-437.33M | -1,800.29%-489.92M | 112.33%17.43M | --9.57M |
| Operating profit | 128.59%17.65M | 97.65%-72.3M | 97.86%-61.74M | -294.21%-3.08B | -425.01%-2.89B | -643.62%-780.69M | -755.81%-529M | -3,690.06%-549.98M | 53.22%-104.98M | -61.81M |
| Financing cost | -62.07%-5.69M | 5.13%-7.36M | 20.21%-3.51M | -0.31%-7.76M | -57.80%-4.4M | -518.31%-7.74M | -700.18%-4.49M | -649.19%-2.79M | -173.14%-1.25M | ---561K |
| Earning before tax | 118.34%11.97M | 97.42%-79.66M | 97.74%-65.25M | -291.33%-3.09B | -423.15%-2.89B | -642.15%-788.42M | -755.31%-533.49M | -3,614.06%-552.76M | 52.76%-106.24M | -62.37M |
| Tax | 378,026.67%113.38M | ---655K | ---30K | ---- | ---- | -31.74%-303K | -104.44%-276K | ---186K | ---230K | ---135K |
| After-tax profit from continuing operations | 292.00%125.34M | 97.40%-80.31M | 97.74%-65.28M | -291.18%-3.09B | -422.98%-2.89B | -640.83%-788.72M | -753.91%-533.76M | -3,615.31%-552.95M | 52.65%-106.47M | -62.51M |
| Earning after tax | 292.00%125.34M | 97.40%-80.31M | 97.74%-65.28M | -291.18%-3.09B | -422.98%-2.89B | -640.83%-788.72M | -753.91%-533.76M | -3,615.31%-552.95M | 52.65%-106.47M | -62.51M |
| Minority profit | ---311K | ---1.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 292.48%125.65M | 97.43%-79.24M | 97.74%-65.28M | -291.18%-3.09B | -422.98%-2.89B | -640.83%-788.72M | -753.91%-533.76M | -3,615.31%-552.95M | 52.65%-106.47M | -62.51M |
| Basic earnings per share | 273.33%0.26 | 97.67%-0.19 | 98.25%-0.15 | -22.74%-8.15 | -81.01%-8.58 | -621.74%-6.64 | -742.59%-4.55 | -3,546.15%-4.74 | 53.30%-0.92 | -0.54 |
| Diluted earnings per share | 273.33%0.26 | 97.67%-0.19 | 98.25%-0.15 | -22.74%-8.15 | -81.01%-8.58 | -544.66%-6.64 | -506.67%-4.55 | -829.41%-4.74 | 47.72%-1.03 | -0.75 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg